NCT05761457

Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR

Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With Platelet Refractoriness

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (estimated)
• Sponsor: The First Affiliated Hospital of Soochow University · Academic / Other
• Sex: All
• Age: 15 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to improve the platelet level of PTR patients; Prevent and improve bleeding; Help patients to successfully through the bone marrow suppression period after chemotherapy; Reduce the overall rate of PTR and allo-immunity; Saving platelet resources and reducing blood burden.

Conditions

• Platelet Transfusion Refractoriness

Interventions

Type	Name	Description
OTHER	Cryopreserved autologous platelet transfusion	Autologous PLTs were collected and transfused as an individualized treatment approach, when the platelet is less than 20\*10E9/L or severe bleeding occurred.

Timeline

• Start date: 2023-03-01
• Primary completion: 2025-01-10
• Completion: 2025-01-10
• First posted: 2023-03-09
• Last updated: 2023-03-09

Locations

1 site across 1 country: China